ArticleIntegrative cancer therapies
Adherence of Patients With Breast Carcinoma and Gynecologic Genital Carcinoma in the Use of Integrative Therapy Recommendations.
Article in Integrative cancer therapies. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundThis study aimed to evaluate differences in adherence to integrative therapy recommendations provided by the Consultation Service for Integrative Medicine (SIM) at the Women's Clinic of the University Hospital Erlangen, Germany, across patient subgroups. The study sought to identify opportunities for further optimization and refinement of the integrative care program.MethodsIn this cross-sectional study, data of 120 women who visited the SIM consultancy were collected at the first presentation (Baseline) and after 3 to 6 months of therapy (Follow-Up) using standardized questionnaires. The adherence variable was defined as the proportion of integrative therapy methods implemented for at least four weeks of the total number of therapy recommendations received per patient. Differences in patient-reported adherence to integrative therapies among cohorts defined by demographic characteristics, lifestyle factors, and tumor-related characteristics were evaluated using independent-samples t-tests and analyses of variance (ANOVA).ResultsThere was no significant difference in adherence with Integrative therapy recommendations in cohorts based on age, education, Body-mass-index (BMI), tumor localization and treatment modality. Factors significantly associated with lower adherence, were low physical activity, defined as self-reported absence of regular exercise, compared with patients reporting approximately 1 hour or 2-4 hours of exercise per week, and presence of distant metastases.ConclusionAdherence with SIM recommendations was significantly lower among patients with low physical activity levels, as well as among patients with distant metastatic disease. This shows that the treatment concepts of the SIM need to be adapted more individually and, in particular, body-based treatments need to be reviewed in order to make them accessible for patients with poorer physical condition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.